Fateh-Moghadam A, Wick M, Simon H
Immun Infekt. 1984 Feb;12(1):45-50.
Seven different commercial intravenous 7S-immunoglobulin preparations have been examined by electrophoresis, immunoelectrophoresis, quantitative determination of immunoglobulins and other proteins, gel chromatography and analytical ultracentrifugation. No significant difference concerning IgG and monomeric immunoglobulin concentrations was observed. The content of IgM, dimers and polymers showed slight, that of IgA considerable differences. All immunoglobulin preparations comply with the European Pharmacopoea requirements. The rate of adverse reactions should be equally low due to similar dimer and polymer contents. IgA-free preparations are considered to be more suitable in primary hypogammaglobulinaemia whereas IgA-containing preparations could be of benefit in acquired hypogammaglobulinaemia. While the presence of an intact immunoglobulin molecule is thought to be essential for its full therapeutic efficacy, the influence of the preparation method is still in debate.
已通过电泳、免疫电泳、免疫球蛋白和其他蛋白质的定量测定、凝胶色谱法和分析超速离心法对七种不同的市售静脉注射7S免疫球蛋白制剂进行了检查。未观察到IgG和单体免疫球蛋白浓度有显著差异。IgM、二聚体和聚合物的含量显示出轻微差异,IgA的含量则有相当大的差异。所有免疫球蛋白制剂均符合欧洲药典要求。由于二聚体和聚合物含量相似,不良反应发生率应该同样较低。无IgA制剂被认为更适合原发性低丙种球蛋白血症,而含IgA制剂可能对获得性低丙种球蛋白血症有益。虽然完整免疫球蛋白分子的存在被认为对其充分的治疗效果至关重要,但制备方法的影响仍存在争议。